A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : Ad5

Search Conditions:
Search Keyword : Ad5
Search Method : Exact match.
Research Area:

Abbreviation: Ad5
Appearance Frequency: 904 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
adenovirus type 5
(695 times)
(254 times)
CAR (84 times)
E1A (24 times)
Ad (17 times)
1975 Radioimmunoassay of human serum antibody specific for adenovirus type 5-purified fiber.
adenovirus 5
(121 times)
(37 times)
CAR (4 times)
FMDV (4 times)
MHC (4 times)
1977 Transformation with specific fragments of adenovirus DNAs. II. Analysis of the viral DNA sequences present in cells transformed with a 7% fragment of adenovirus 5 DNA.
Ad serotype 5
(43 times)
(14 times)
Ad (36 times)
CAR (12 times)
Ad35 (8 times)
1998 New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Ad type 5
(23 times)
(18 times)
Ad (21 times)
CAR (6 times)
ORF6 (2 times)
1980 Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2.
adenovirus vectors based on human serotype 5
(5 times)
Genetics, Medical
(2 times)
CAR (2 times)
Ad11 (1 time)
Ang (1 time)
2002 Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency.
adenovirus 5 vector
(3 times)
(1 time)
Ad5-HA (1 time)
AFP (1 time)
DC (1 time)
2001 A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
adenoviruses based on serotype 5
(3 times)
(1 time)
CAR (1 time)
2003 A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
Adenovirus type 5 vector
(2 times)
Genetics, Medical
(1 time)
Env (1 time)
HIV-1 (1 time)
HVR5 (1 time)
2009 Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
Ad vectors is not limited to serotype 5
(1 time)
Molecular Biology
(1 time)
Ad (1 time)
2007 The influence of blood on in vivo adenovirus bio-distribution and transduction.
10  Ad5 vectors with nonmodified fibers
(1 time)
(1 time)
--- 2007 Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.
11  adeno type 5
(1 time)
(1 time)
2a, ribamidine (1 time)
JE (1 time)
PT (1 time)
1992 Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.
12  adenovirus expressing human IGFBP-5
(1 time)
(1 time)
IGFBP (1 time)
2006 Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.
13  adenovirus type 5 gene transfer vector
(1 time)
Cell Biology
(1 time)
AMs (1 time)
HIV (1 time)
LTR (1 time)
2010 Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.
14  adenovirus vectors, primarily developed from serotype 5
(1 time)
Allergy and Immunology
(1 time)
Env (1 time)
2007 Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.
15  adenoviruses, such as serotype 5
(1 time)
(1 time)
--- 2007 Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival.
16  afforded by boosting BCG-vaccinated cattle with a human type 5
(1 time)
Allergy and Immunology
(1 time)
BCG (1 time)
2014 Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
17  anti-Ad serotype 5
(1 time)
(1 time)
Ad (1 time)
CF (1 time)
PU (1 time)
1999 Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.